| Mohammad Najim Alberawi, MBBS | |
|
940 Ne 13th St Ste 3g3210, Oklahoma City, OK 73104-5008 | |
| (405) 271-5125 | |
| Not Available |
| Full Name | Mohammad Najim Alberawi |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 940 Ne 13th St Ste 3g3210, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336693845 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085N0700X | Radiology - Neuroradiology | 35966 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Arbuckle Memorial Hospital | Sulphur, OK | Hospital |
| Norman Regional | Norman, OK | Hospital |
| Duncan Regional Hospital, Inc | Duncan, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
Baxter International Inc. today announced that its Phase III clinical study of immunoglobulin did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.
The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings- are published in the Journal of General Internal Medicine- in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
BRAVADA International Ltd. announced today that it has added Footzyrolls and Footzy Flops to its product mix at www.BravadaWomen.com as well as its BRAVADA Women's Athletica retail stores. As a women's fitness, health and lifestyle brand, BRAVADA seeks to continually expand its range of products to provide only the very best in fitness and lifestyle related ideas to its customers.
Insects are about to be analyzed in a new way by a host of Virginia Tech engineering faculty. They will be using some fancy state-of-the-art equipment, such as a kilometer-long synchrotron x-ray light source, which might be enough to scare any bug. And first up will be beetles, grasshoppers and silk moths because they have some endearing characteristics.
› Verified 3 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
Baxter International Inc. today announced that its Phase III clinical study of immunoglobulin did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.
The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings- are published in the Journal of General Internal Medicine- in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
BRAVADA International Ltd. announced today that it has added Footzyrolls and Footzy Flops to its product mix at www.BravadaWomen.com as well as its BRAVADA Women's Athletica retail stores. As a women's fitness, health and lifestyle brand, BRAVADA seeks to continually expand its range of products to provide only the very best in fitness and lifestyle related ideas to its customers.
Insects are about to be analyzed in a new way by a host of Virginia Tech engineering faculty. They will be using some fancy state-of-the-art equipment, such as a kilometer-long synchrotron x-ray light source, which might be enough to scare any bug. And first up will be beetles, grasshoppers and silk moths because they have some endearing characteristics.
› Verified 3 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
Baxter International Inc. today announced that its Phase III clinical study of immunoglobulin did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.
The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings- are published in the Journal of General Internal Medicine- in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
BRAVADA International Ltd. announced today that it has added Footzyrolls and Footzy Flops to its product mix at www.BravadaWomen.com as well as its BRAVADA Women's Athletica retail stores. As a women's fitness, health and lifestyle brand, BRAVADA seeks to continually expand its range of products to provide only the very best in fitness and lifestyle related ideas to its customers.
Insects are about to be analyzed in a new way by a host of Virginia Tech engineering faculty. They will be using some fancy state-of-the-art equipment, such as a kilometer-long synchrotron x-ray light source, which might be enough to scare any bug. And first up will be beetles, grasshoppers and silk moths because they have some endearing characteristics.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mohammad Najim Alberawi, MBBS 1653 W Congress Pkwy, Dept Of Diagnostic Radiology Jelke Building 181, Chicago, IL 60612-3833 Ph: (847) 736-1128 | Mohammad Najim Alberawi, MBBS 940 Ne 13th St Ste 3g3210, Oklahoma City, OK 73104-5008 Ph: (405) 271-5125 |
News Archive
Baxter International Inc. today announced that its Phase III clinical study of immunoglobulin did not meet its co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.
The relationship between body mass index (BMI) appears to be stronger in adults without diabetes than those with existing diabetes. These findings- are published in the Journal of General Internal Medicine- in a study by Chandra Jackson of the Harvard School of Public Health and colleagues.
Synthon has announced that its subsidiary Synthon Pharmaceuticals, Inc. has received tentative approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for tadalafil tablets, 20 mg on April 13, 2012. Synthon's product is a generic and bioequivalent version of Eli Lilly & Co and United Therapeutics' Adcirca® tablets, which are indicated for the treatment of pulmonary arterial hypertension to improve exercise ability.
BRAVADA International Ltd. announced today that it has added Footzyrolls and Footzy Flops to its product mix at www.BravadaWomen.com as well as its BRAVADA Women's Athletica retail stores. As a women's fitness, health and lifestyle brand, BRAVADA seeks to continually expand its range of products to provide only the very best in fitness and lifestyle related ideas to its customers.
Insects are about to be analyzed in a new way by a host of Virginia Tech engineering faculty. They will be using some fancy state-of-the-art equipment, such as a kilometer-long synchrotron x-ray light source, which might be enough to scare any bug. And first up will be beetles, grasshoppers and silk moths because they have some endearing characteristics.
› Verified 3 days ago
Dr. Jennifer Kathleen Hinkle, MD Radiology Medicare: Medicare Enrolled Practice Location: 921 Ne 13th St, Oklahoma City, OK 73104 Phone: 405-456-2589 | |
Dr. Bryan Lee Vanzandt, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4625 S Western Ave, Oklahoma City, OK 73109 Phone: 405-632-2323 Fax: 405-631-9315 | |
Charles Eric Eckman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 14101 Parkway Commons, Oklahoma City, OK 73134 Phone: 405-749-6277 | |
Robert K Gelczer, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St., Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
Vikas Vij, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Suite C-40, Oklahoma City, OK 73112 Phone: 405-945-4741 Fax: 888-972-5320 | |
William G Phillips, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2224 Nw 50th St, Suite 276w, Oklahoma City, OK 73112 Phone: 405-858-2350 | |
Ronald Ray Magee, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5224 E I 240 Service Rd Ste 303, Oklahoma City, OK 73135 Phone: 405-608-3800 Fax: 405-628-6477 |